Original Research

Published on 23 May 2023

A novel benzothiazole derivative induces apoptosis via the mitochondrial intrinsic pathway producing antitumor activity in colorectal cancer

in Pharmacology of Anti-Cancer Drugs

Jing Zhou
Rongce Zhao
Haoxuan Zhou
Shuping Yang
Feiyan Tao
Yongmei Xie
Hongli Wang
Jingping Yun

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1196158

1,849 views
6 citations

Case Report

Published on 23 May 2023

Ripretinib in combination with tyrosine kinase inhibitor as a late-line treatment option for refractory gastrointestinal stromal tumors: two case reports and literature review

in Pharmacology of Anti-Cancer Drugs

Yefan Zhang
Zhen Huang

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1122885

2,264 views
4 citations

Systematic Review

Published on 22 May 2023

Association between immune-related adverse events and immunotherapy efficacy in non-small-cell lung cancer: a meta-analysis

in Pharmacology of Anti-Cancer Drugs

Li Lin
Yu Liu
Chen Chen
Anhua Wei
Wei Li

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1190001

3,695 views
12 citations

Original Research

Published on 22 May 2023

Development of a novel copper metabolism-related risk model to predict prognosis and tumor microenvironment of patients with stomach adenocarcinoma

in Pharmacology of Anti-Cancer Drugs

Dongjie Sun
Haiying Zhang
Chi Zhang

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1185418

2,050 views
1 citation

Review

Published on 22 May 2023

The role of peptides in reversing chemoresistance of breast cancer: current facts and future prospects

in Pharmacology of Anti-Cancer Drugs

Yongxiu Huang
Hongyao Peng
Anqi Zeng
Linjiang Song

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1188477

2,938 views
3 citations

Original Research

Published on 22 May 2023

A novel T-cell exhaustion-related feature can accurately predict the prognosis of OC patients

in Pharmacology of Anti-Cancer Drugs

Kemiao Yuan
Songyun Zhao
Bicheng Ye
Qi Wang
Yuan Liu
Pengpeng Zhang
Jiaheng Xie
Hao Chi
Yu Chen
Chao Cheng

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1192777

3,612 views
15 citations

Original Research

Published on 22 May 2023

Bevacizumab loaded CalliSpheres® bronchial arterial chemoembolization combined with immunotherapy and targeted therapy for advanced lung adenocarcinoma

in Pharmacology of Anti-Cancer Drugs

Haitao Liu
Yahua Li
Zongming Li
Xinwei Han
Kewei Ren

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1170344

1,905 views
1 citation

Review

Published on 22 May 2023

The emerging roles and mechanism of N6-methyladenosine (m6A) modifications in urologic tumours progression

in Pharmacology of Anti-Cancer Drugs

Wenhao Zhu
Renshan Zhao
Xiaomin Guan
Xu Wang

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1192495

2,147 views
3 citations

Original Research

Published on 22 May 2023

Integrating network pharmacology and experimental validation to explore the effect and mechanism of AD-1 in the treatment of colorectal cancer

in Pharmacology of Anti-Cancer Drugs

Jiawei Li
Fangfang Li
Yuqing Zhao
Dan Jin

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1159712

1,998 views
2 citations

Original Research

Published on 22 May 2023

Indoleamine 2,3-dioxygenase 1 promotes osteosarcoma progression by regulating tumor-derived exosomal miRNA hsa-miR-23a-3p

in Pharmacology of Anti-Cancer Drugs

Dan Yang
Yinxian Chen
Zhen Ning Tony He
Yichen Wang
Chenghui Ke
Yi Luo
Sun Wang
Qichao Ma
Mengjie Chen
Qing Yang

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1194094

2,194 views
2 citations

Review

Published on 19 May 2023

A review of nanomaterials from synthetic and natural molecules for prospective breast cancer nanotherapy

in Pharmacology of Anti-Cancer Drugs

Pankaj Kumar
Bharti Mangla
Shamama Javed
Waquar Ahsan
Pankaj Musyuni
Durgaramani Sivadasan
Saad S. Alqahtani
Geeta Aggarwal

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1149554

5,407 views
10 citations

Original Research

Published on 19 May 2023

Beta-blocker exposure and survival outcomes in patients with advanced pancreatic ductal adenocarcinoma: a retrospective cohort study (BETAPANC)

in Pharmacology of Anti-Cancer Drugs

Antoine Le Bozec
Mathias Brugel
Zoubir Djerada
Marya Ayad
Marine Perrier
Claire Carlier
Damien Botsen
Pierre Nazeyrollas
Olivier Bouché
Florian Slimano

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1137791

2,035 views

Brief Research Report

Published on 18 May 2023

Evaluation of the potential herb-drug interaction between Bojungikki-tang and PD-L1 immunotherapy in a syngeneic mouse model

in Pharmacology of Anti-Cancer Drugs

Sung-Yoon Yang
Jin-Mu Yi
Jaemoo Chun
Seongwon Park
Tham Thi Bui
Hwi-Yeol Yun
Jung-Woo Chae
Mi-Kyung Jeong

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1181263

2,222 views
2 citations

Original Research

Published on 18 May 2023

The mechanism of trans-δ-viniferin inhibiting the proliferation of lung cancer cells A549 by targeting the mitochondria

in Pharmacology of Anti-Cancer Drugs

Ruochun Yin
Yiling Zhang
Liping Su
Dongdong Chen
Shidi Lou
Xuecai Luo
Lin Wang
Rupei Tang
Liang Zhang
Xiaohe Tian

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1190127

1,637 views
1 citation

Original Research

Published on 17 May 2023

Acacetin exerts antitumor effects on gastric cancer by targeting EGFR

in Pharmacology of Anti-Cancer Drugs

Guangtao Zhang
Jiahuan Dong
Lu Lu
Yujing Liu
Dan Hu
Yuanmin Wu
Aiguang Zhao
Hanchen Xu

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1121643

2,877 views
5 citations

Original Research

Published on 17 May 2023

Integrated machine learning and bioinformatic analyses used to construct a copper-induced cell death-related classifier for prognosis and immunotherapeutic response of hepatocellular carcinoma patients

in Pharmacology of Anti-Cancer Drugs

Shuai Zhao
Shuxian Chen
Wangrui Liu
Shiyin Wei
Xinrui Wu
Dan Cui
Lifeng Jiang
Siyu Chen
Jian Wang

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1188725

3,238 views
4 citations

Navigation group

Articles

A novel benzothiazole derivative induces apoptosis via the mitochondrial intrinsic pathway producing antitumor activity in colorectal cancer

Ripretinib in combination with tyrosine kinase inhibitor as a late-line treatment option for refractory gastrointestinal stromal tumors: two case reports and literature review

Association between immune-related adverse events and immunotherapy efficacy in non-small-cell lung cancer: a meta-analysis

Development of a novel copper metabolism-related risk model to predict prognosis and tumor microenvironment of patients with stomach adenocarcinoma

The role of peptides in reversing chemoresistance of breast cancer: current facts and future prospects

A novel T-cell exhaustion-related feature can accurately predict the prognosis of OC patients

Bevacizumab loaded CalliSpheres® bronchial arterial chemoembolization combined with immunotherapy and targeted therapy for advanced lung adenocarcinoma

The emerging roles and mechanism of N6-methyladenosine (m6A) modifications in urologic tumours progression

Integrating network pharmacology and experimental validation to explore the effect and mechanism of AD-1 in the treatment of colorectal cancer

Indoleamine 2,3-dioxygenase 1 promotes osteosarcoma progression by regulating tumor-derived exosomal miRNA hsa-miR-23a-3p

A review of nanomaterials from synthetic and natural molecules for prospective breast cancer nanotherapy

Beta-blocker exposure and survival outcomes in patients with advanced pancreatic ductal adenocarcinoma: a retrospective cohort study (BETAPANC)

Evaluation of the potential herb-drug interaction between Bojungikki-tang and PD-L1 immunotherapy in a syngeneic mouse model

The mechanism of trans-δ-viniferin inhibiting the proliferation of lung cancer cells A549 by targeting the mitochondria

Acacetin exerts antitumor effects on gastric cancer by targeting EGFR

Integrated machine learning and bioinformatic analyses used to construct a copper-induced cell death-related classifier for prognosis and immunotherapeutic response of hepatocellular carcinoma patients